Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,855,731
+$1,060,754 QoQ
Shares Held
210,911
-29.6% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $19,128,320,487 across 19 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,358,401 | $5,227,597,337 | |
| 2 | JNJ |
Johnson & Johnson
|
13,211,475 | $3,355,318,297 | |
| 3 | ABBV |
AbbVie Inc.
|
8,163,806 | $2,054,340,133 | |
| 4 | AZN |
Astrazeneca PLC
|
10,427,503 | $1,977,263,112 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,293,086 | $1,836,661,547 | |
| 6 | AMGN |
Amgen Inc
|
4,328,785 | $1,567,539,618 | |
| 7 | PFE |
Pfizer Inc
|
32,814,260 | $790,167,373 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,094,886 | $696,907,326 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,855,731 | 210,911 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,794,977 | 299,663 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,980,399 | 276,207 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,073,474 | 287,779 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,374,629 | 451,925 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $5,373,231 | 360,862 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $3,509,388 | 235,214 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,737,459 | 143,098 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,914,966 | 189,129 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $3,433,929 | 182,656 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $3,001,690 | 208,162 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,889,503 | 224,050 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,761,804 | 276,877 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,149,793 | 218,954 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,374,972 | 299,856 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,094,151 | 345,904 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,898,618 | 411,811 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $17,351,295 | 496,745 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,541,405 | 411,869 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,674,820 | 539,031 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,659,889 | 715,793 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||